Pittsburgh, PA, United States of America

Adriana Gambino

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adriana Gambino. Retrieved from https://idiyas.com/inventor/adriana-gambino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adriana Gambino: Innovator in Antidote Development

Introduction

Adriana Gambino is a notable inventor based in Pittsburgh, PA. She has made significant contributions to the field of pharmaceuticals, particularly in developing antidotes against organophosphorus nerve agents. Her work is crucial in addressing the dangers posed by these toxic compounds.

Latest Patents

Adriana Gambino holds a patent for "Analogs of 2-pralidoxime as antidotes against organophosphorus nerve agents." This patent includes compounds that are useful in treating exposure to organophosphorus compounds, such as nerve agents and pesticides. The patent also covers pharmaceutical compositions and dosage forms that comprise these compounds. Furthermore, it outlines methods for treating patients exposed to these harmful agents.

Career Highlights

Adriana is affiliated with the University of Pittsburgh, where she conducts her research and development work. Her innovative approach to creating antidotes has positioned her as a key figure in the field of toxicology and emergency medicine.

Collaborations

Adriana has collaborated with esteemed colleagues, including Kazunori Koide and George D Leikauf. These partnerships have enhanced her research efforts and contributed to the advancement of antidote development.

Conclusion

Adriana Gambino's work in developing antidotes against organophosphorus nerve agents showcases her dedication to improving public health and safety. Her innovative contributions continue to have a lasting impact in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…